Back to results
US 7,731,987 B2Granted
Implantable medical device comprising a pro-healing poly(ester-amide)
AssigneeAdvanced Cardiovascular Systems, Inc.
InventorsJessica Reneé DesNoyer, Mikael Trollsas, Syed F. A. Hossainy
Life of this patent
Estimating the term…
Abstract
The present invention relates to implantable medical devices, in particular stents, comprising pro-healing poly(ester-amide)s.
Claims42
An implantable medical device, comprising:
- a device body and at least one layer comprising a poly(ester-amide) having the formula:
- an optional primer layer disposed over the device body;
- a drug reservoir layer disposed over the device body or the primer layer, if opted, wherein the drug reservoir layer comprises one or more therapeutic agents;
- an optional rate-controlling layer disposed over at least a portion of the drug reservoir layer, if opted;
- and,
- an optional top-coat layer disposed as an outermost layer over the device body, the primer layer, if opted, the drug reservoir layer, if opted, or the rate-limiting layer, if opted,
- wherein:
- m is an integer from 0 to about 200;
- p is an integer from 0 to about 200;
- n is an integer from 1 to about 200;
- r is an integer from 1 to about 3000;
- Mw is from about 10,000 Da to about 1,000,000 Da;
- s is a number from 0 to 1, inclusive;
- t is a number from 0 to 1, inclusive;
- v is a number from 0 to 1, inclusive;
- wherein:
- s+t+v=1;
- X has the chemical structure:
- Y has the chemical structure:
- Z has the chemical structure:
- wherein:
- R1, R1′ and R4 are independently selected from the group consisting of (1C-12C)alkyl and (2C-12C)alkenyl;
- R2, R2′, R2″ and R2′″ are independently selected from the group consisting of hydrogen and (1C-4C)alkyl, wherein:
- the alkyl group is optionally substituted with a moiety selected from the group consisting of —OH, —O(1C-4C)alkyl, —SH, —S(1C-4C)alkyl, —SeH, —COR6, —NHC(NH)NH2, imidazol-2-yl, imidazole-5-yl,
- indol-3-yl, phenyl, 4-hydroxyphenyl and 4-[(1C-4C)alkylO]phenyl, wherein:
- R6 is selected from the group consisting of —OH, —O(1C-4C)alkyl, —NH2, —NH(1C-4C)alkyl, —N(1C-4C)alkyl1(1C-4C)alkyl2, a stable nitroxide, —O(CH2)2OP(═O)(O−)OCH2CH2N30 (CH3)3, —O(CH2CH2O)qCH2CH2OR7 and
- where:
- the stable nitroxide is selected from the group consisting of
- R7 is selected from the group consisting of hydrogen, (1C-4C)alkyl, —C(O)CH═CH2, —C(O)C(CH3)═CH2 and —O(CH2)2OP(═O)(O−)OCH2CH2N+(CH3)3;
- or
- one or more of R2, R2′, R2″ and R2′″ may form a bridge between the carbon to which it is attached and the adjacent nitrogen, the bridge comprising
- —CH2CH2CH2—;
- R3 is selected from the group consisting of (1C-12C)alkyl and(2C-12C)alkenyl, (3C-8C) cycloalkyl, (3C-8C)bicycloalkyl and
- —(CH2CH2O)qCH2CH2—;
- R5 is selected from the group consisting of —CH(COR6)CH2S—, —CH(COR6)CH2O—, —(CH2)4CH(COR6)NH—, —CH(COR6)CH(CH3)O—,
- and
- and,
- q is an integer from 1 to 600, inclusive.
35 more elements
An implantable medical device, comprising:
- a device body and at least one layer comprising a poly(ester-amide) having the formula:
- an optional primer layer disposed over the device body;
- a drug reservoir layer disposed over the device body or the primer layer, if opted, wherein the drug reservoir layer comprises one or more therapeutic agents;
- an optional rate-controlling layer disposed over at least a portion of the drug reservoir layer, if opted;
- and,
- an optional top-coat layer disposed as an outermost layer over the device body, the primer layer, if opted, the drug reservoir layer, if opted, or the rate-limiting layer, if opted,
- wherein:
- m is an integer from 0 to about 200;
- p is an integer from 0 to about 200;
- n is an integer from 1 to about 200;
- r is an integer from 1 to about 3000;
- Mw is from about 10,000 Da to about 1,000,000 Da;
- s is a number from 0 to 1, inclusive;
- t is a number from 0 to 1, inclusive;
- v is a number from 0 to 1, inclusive;
- wherein:
- s+t+v=1;
- X has the chemical structure:
- Y has the chemical structure:
- Z has the chemical structure:
- wherein:
- R1, R1′ and R4 are independently selected from the group consisting of (1C-12C)alkyl and (2C-12C)alkenyl;
- R2, R2′, R2″ and R2′″ are independently selected from the group consisting of hydrogen and (1C-4C)alkyl, wherein:
- the alkyl group is optionally substituted with a moiety selected from the group consisting of —OH, —O(1C-4C)alkyl, —SH, —S(1C-4C)alkyl, —SeH, —COR6, —NHC(NH)NH2, imidazol-2-yl, imidazole-5-yl,
- indol-3-yl, phenyl, 4-hydroxyphenyl and 4-[(1C-4C)alkylO]phenyl, wherein:
- R6 is selected from the group consisting of —NH2, —NH(1C-4C)alkyl, —N(1C-4C)alkyl1(1C-4C)alkyl2, a stable nitroxide, —O(CH2)2OP(═O)(O−)OCH2CH2N+(CH3)3, and
- —O(CH2CH2O)qCH2CH2OR7;
- where:
- R7 is selected from the group consisting of hydrogen, (1C-4C)alkyl, —C(O)CH═CH2, —C(O)C(CH3)═CH2 and
- —O(CH2)2OP(═O)(O−)OCH2CH2N+(CH3)3;
- or
- one or more of R2, R2′, R2″ and R2′″ may form a bridge between the carbon to which it is attached and the adjacent nitrogen, the bridge comprising
- —CH2CH2CH2—;
- R3 is selected from the group consisting of(1C-12C)alkyl and (2C-12C)alkenyl, (3C-8C) cycloalkyl, (3C-8C)bicycloalkyl and
- —(CH2CH2O)qCH2CH2—;
- R5 is selected from the group consisting of —CH(COR6)CH2S—,
- —CH(COR6)CH2O—, —CH(COR6)(CH2)4NH—,
- —CH(COR6)CH(CH3)O—,
- and,
- q is an integer from 1 to 600, inclusive.
37 more elements
Dependencies are inferred from the claim text.